ZIVO · OTC
Zivo Bioscience (ZIVO) Stock Price & Fundamentals
Zivo Bioscience (ZIVO) closed at $517.96 on Oct 9, 2026, up 0.12% from the previous close of $517.35.
Share price, past year
1Y +30.62%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $517.96 |
| Sep 30, 2026 | $507.64 |
| Aug 31, 2026 | $486.35 |
| Jul 31, 2026 | $482.84 |
| Jun 30, 2026 | $465.45 |
| May 29, 2026 | $476.73 |
| Apr 30, 2026 | $467.45 |
| Mar 31, 2026 | $435.15 |
| Feb 27, 2026 | $446.93 |
| Jan 30, 2026 | $436.26 |
| Dec 31, 2025 | $440.59 |
| Nov 28, 2025 | $408.97 |
| Oct 31, 2025 | $400.14 |
Key statistics
- Market cap
- $1.98B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 3.8M
- Dividend yield
- —
- 52-week range
- $389.82 – $517.96
Zivo Bioscience's market cap is $1.98B, based on a share price of $517.96 and 3.8M shares outstanding as of Sep 30, 2025.
Financials
Zivo Bioscience reported revenue of $157.22K for fiscal 2024, up 468.61% from fiscal 2023.
Zivo Bioscience reported a net loss of $13.38M in fiscal 2024.
Fiscal 2024 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $157.22K | +468.6% | −$13.38M | −8,513.4% | −$4.23 | — |
| FY2023ended Dec 31, 2023 | $27.65K | — | −$7.78M | −28,127.3% | −$4.60 | — |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$8.75M | — | — | — |
| FY2021ended Dec 31, 2021 | $0.00 | −100.0% | −$8.76M | — | — | — |
| FY2020ended Dec 31, 2020 | $20.00K | — | −$9.11M | −45,528.7% | −$0.02 | — |
| FY2019ended Dec 31, 2019 | $0.00 | — | −$11.51M | — | −$0.04 | — |
| FY2018ended Dec 31, 2018 | $0.00 | — | −$14.64M | — | −$0.09 | — |
| FY2017ended Dec 31, 2017 | $0.00 | — | −$10.04M | — | −$0.07 | — |
| FY2016ended Dec 31, 2016 | $0.00 | — | −$6.06M | — | −$0.05 | — |
| FY2015ended Dec 31, 2015 | $0.00 | — | −$5.79M | — | −$0.04 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | $65.63K | −$1.03M | −$0.27 |
| Q2 FY2025ended Jun 30, 2025 | $53.40K | −$1.64M | −$0.43 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$4.21M | −$1.12 |
| Q4 FY2024ended Dec 31, 2024 | $90.00K | −$1.60M | −$0.31 |
| Q3 FY2024ended Sep 30, 2024 | $31.50K | −$2.27M | −$0.67 |
| Q2 FY2024ended Jun 30, 2024 | $0.00 | −$8.24M | −$2.78 |
| Q1 FY2024ended Mar 31, 2024 | $35.72K | −$1.28M | −$0.47 |
| Q4 FY2023ended Dec 31, 2023 | $11.80K | −$1.91M | — |
Company profile
- Name
- Zivo Bioscience, Inc.
- Ticker
- ZIVO
- Exchange
- OTC
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 21 E. Long Lake Road, Suite 100, Bloomfield Hills, MI 48304
- Incorporated in
- NV
- Fiscal year ends
- December
- SEC CIK
- 0001101026
Recent SEC filings
- Mar 30, 2026
- Dec 23, 2025
- Nov 14, 2025
- Sep 10, 2025
- Aug 18, 2025
- Aug 14, 2025
- Jul 14, 2025
- Jun 11, 2025
Frequently asked questions
What is Zivo Bioscience's stock price?
Zivo Bioscience (ZIVO) closed at $517.96 on Oct 9, 2026, up 0.12% from the previous close of $517.35.
What is Zivo Bioscience's market cap?
Zivo Bioscience's market cap is $1.98B, based on a share price of $517.96 and 3.8M shares outstanding as of Sep 30, 2025.
How much revenue does Zivo Bioscience make?
Zivo Bioscience reported revenue of $157.22K for fiscal 2024, up 468.61% from fiscal 2023.
Sources and methodology
Fundamentals come from Zivo Bioscience, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures